NOTCH3
NOTCH3
NOTCH3 is a gene that encodes a protein belonging to the Notch family of receptors, which are involved in a wide range of developmental processes and cellular functions. The NOTCH3 protein plays a crucial role in the regulation of cell fate decisions, proliferation, and apoptosis. Mutations in the NOTCH3 gene are associated with a variety of human diseases, most notably cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL).
Structure[edit]
The NOTCH3 gene is located on chromosome 19p13.2 and consists of 33 exons. The NOTCH3 protein is a single-pass transmembrane receptor that is composed of several distinct domains:
- Extracellular domain: Contains multiple epidermal growth factor (EGF)-like repeats, which are involved in ligand binding.
- Transmembrane domain: Anchors the receptor in the cell membrane.
- Intracellular domain: Contains a RAM domain, ankyrin repeats, and a PEST sequence, which are involved in signal transduction and protein stability.
Function[edit]
NOTCH3 is primarily expressed in vascular smooth muscle cells and plays a critical role in maintaining vascular integrity and function. The activation of NOTCH3 signaling involves the binding of ligands such as Jagged and Delta-like proteins, leading to proteolytic cleavage and release of the intracellular domain. This intracellular domain translocates to the nucleus, where it influences the transcription of target genes involved in cell differentiation and proliferation.
Clinical Significance[edit]
Mutations in the NOTCH3 gene are the primary cause of CADASIL, a hereditary stroke disorder characterized by recurrent subcortical ischemic events and cognitive decline. These mutations typically involve the addition or deletion of cysteine residues in the EGF-like repeats, leading to abnormal protein folding and function.
CADASIL[edit]
CADASIL is an autosomal dominant condition that presents with migraine headaches, mood disturbances, and progressive cognitive impairment. The diagnosis is confirmed by genetic testing for NOTCH3 mutations or by skin biopsy showing granular osmiophilic material in the walls of small blood vessels.
Other Conditions[edit]
In addition to CADASIL, alterations in NOTCH3 signaling have been implicated in other vascular disorders and certain types of cancer, although the exact mechanisms remain under investigation.
Research Directions[edit]
Current research on NOTCH3 focuses on understanding the molecular mechanisms underlying its role in vascular biology and disease. Therapeutic strategies aimed at modulating NOTCH3 signaling are being explored as potential treatments for CADASIL and other related conditions.
Also see[edit]
-
CADASIL - very high magnification
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian

